Search Results for "propensity-score"
-
Cook M
,
Beachler DC
,
Parlett LE
,
Cochetti PT
,
Finkle WD
,
Lanes S
.
Abstract 5050: testosterone supplementation in relation to prostate cancer in a us commercial insurance claims database
. Poster presented at:
2019
American Association for Cancer Research (AACR)
Annual Meeting;
March 29 -
April 03, 2019;
Atlanta, GA, US
. https://aacrjournals.org/cancerres/article/79/13_Supplement/5050/636990/Abstract-5050-Testosterone-supplementation-in
. doi: 10.1158/1538-7445.AM2019-5050
.
-
Parlett LE
,
Ball K
,
Pipkin CA
,
Kappelman MD
,
Bocage C
,
Long MD
.
Compared to thiopurines and tumor necrosis factor inhibitors novel biologics are associated with reduced risk of non-melanoma skin cancer among patients with inflammatory bowel disease
. Poster presented at:
2024
International Society for Pharmacoepidemiology
Annual Meeting;
August 24 -
August 28, 2024;
Berlin, DE
.
-
Kappelman MD
,
Adimadhyam S
,
Hou L
et al
.
Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with crohn's disease
.Am J Gastroenterol.
2023;
118
(4)
: 674-84
. doi: 10.14309/ajg.0000000000002068
.
-
Cook M
,
Beachler DC
,
Parlett LE
et al
.
Testosterone therapy in relation to prostate cancer in a U.S. commercial insurance claims database
.Cancer Epidemiol Biomarkers Prev.
2020;
29
(1)
: 236-45
. doi: 10.1158/1055-9965.EPI-19-0619
.